Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Agastya Belur

New Haven, CT Medical Doctor

NPI 1154826600 CMS profile 11283500

20 York St, New Haven, CT 06510

Open in the dashboard

General payments

$36,600

122 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Agastya Belur of New Haven, CT is reported in the CMS Open Payments database as having received $36,600 across 122 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $31,881 71
2024 General $2,879 11
2023 General $1,216 19
2022 General $521 15
2021 General $104 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Agastya Belur
  • Connecticut median
  • Middle half of Connecticut
  • National median

In program year 2025, general payments to Agastya Belur were reported at $31,881. Among 12,665 Connecticut profiles paid that year, the median was $167 and the middle half received between $54 and $639.

Show as a table
Year Agastya Belur Connecticut median Middle half National median
2019 $0 $163 $50–$671 $163
2020 $0 $111 $33–$382 $114
2021 $104 $124 $39–$443 $132
2022 $521 $138 $45–$535 $149
2023 $1,216 $148 $47–$556 $160
2024 $2,879 $157 $49–$599 $164
2025 $31,881 $167 $54–$639 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Medtronic, Inc. $32,043 64 payments
  2. Abbott Laboratories $1,763 14 payments
  3. Edwards Lifesciences Corporation $731 2 payments
  4. Terumo Medical Corporation $466 7 payments
  5. Boston Scientific Corporation $405 14 payments
  6. Inari Medical, Inc. $325 3 payments
  7. AstraZeneca Pharmaceuticals LP $304 6 payments
  8. Penumbra, Inc. $141 1 payment
  9. E.R. Squibb & Sons, L.L.C. $116 1 payment
  10. Abiomed $88 2 payments
  11. Other $218 8 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Grant $30,392 2 payments
  2. Food and Beverage $3,731 110 payments
  3. Travel and Lodging $2,155 8 payments
  4. Education $322 2 payments
Products named General payments · program years 2021–2025
  1. MITRACLIP $1,374 11 payments
  2. COREVALVE EVOLUT R $1,296 55 payments
  3. GLIDESHEATH SLENDER $394 4 payments
  4. FLOWTRIEVER CATHETER, S $339 4 payments
  5. CT THROMBECTOMY SYSTEM KIT $311 2 payments
  6. FARXIGA $304 6 payments
  7. ONYX FRONTIER $259 3 payments
  8. General Vascular Access IC $160 1 payment
  9. Perclose ProStyle $159 1 payment
  10. Indigo System $141 1 payment
  11. Other $892 24 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

122 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record